🧘
South China Morning Post1h ago
Hong Kong Biotech Uses AI to Cut Drug Development to 18 Months
A Hong Kong biotech startup is using artificial intelligence to design "nano-rockets" that deliver life-saving drugs, slashing development time from years to just 18 months.
METiS TechBio's stock soared 173% on its market debut as investors rushed to back the breakthrough technology.
Want to know more?
1/4